63
Participants
Start Date
January 1, 2025
Primary Completion Date
January 1, 2026
Study Completion Date
February 1, 2026
dextrose 5%
patients will receive 5 % dextrose infusion
Dextrose 10%
patients will receive 10 % dextrose infusion (25gm/ 250 mL)
0.9% saline
patients will receive infused IV 0.9 % saline
Assiut University
OTHER